期刊论文详细信息
European Medical Journal Oncology
Editor's Pick: Tumour-Associated Hypoxia: Can We Give Chimeric Antigen Receptor T Cells More Breathing Space?
article
Karen I Larios Martinez1  Paris Kosti1  Anna Schurich2  James N Arnold1  John Maher1 
[1] School of Cancer and Pharmaceutical Sciences, King’s College London, Faculty of Life Sciences and Medicine, Guy’s Campus;School of Immunology and Microbial Sciences, King’s College London, Faculty of Life Sciences and Medicine, Guy’s Campus
关键词: Adoptive cell therapy;    chimeric antigen receptor (CAR);    CAR-T cells;    hypoxia-inducible factor-1-α (HIF1-α);    hypoxia-responsive elements (HRE);    hypoxia;    on-target off-tumour;    immunotherapy;    oncology;    oxygen-sensitive CAR.;   
DOI  :  10.33590/emj/20-00076
学科分类:社会科学、人文和艺术(综合)
来源: European Medical Journal
PDF
【 摘 要 】

Immunotherapy using chimeric antigen receptor (CAR)-engineered T cells has encountered important limitations in the transition of their use from liquid to solid tumours. Success is dependent upon T-cell trafficking to, and functional persistence within, tumours that often present a metabolically and immunologically hostile microenvironment. Moreover, CAR targets that are tumour specific are extremely scarce. To address these issues, several strategies have been proposed to improve both tumour selectivity and safety. One approach involves the engineering of CAR-T cells that only deploy their effector function at tumour sites. Conceptually, a solution for this exploits the oxygen-limited nature of advanced tumour deposits through the engineering of CAR that are exclusively expressed or activated under conditions of profound hypoxia. T cells have a complex inter-relationship with oxygen, which also needs to be factored into the refinement of these technologies. Ideally, oxygen-sensing CAR should only function when oxygen tension is below 2%, as is commonly the case in solid tumours but rare in healthy tissue. Successful advancement of such technologies presents opportunities for solid tumour immunotherapy because it should broaden the target repertoire that may safely be exploited in this context.

【 授权许可】

CC BY-NC   

【 预 览 】
附件列表
Files Size Format View
RO202302050000195ZK.pdf 739KB PDF download
  文献评价指标  
  下载次数:3次 浏览次数:1次